207 related articles for article (PubMed ID: 29915524)
21. Pre-Treatment Integrase Inhibitor Resistance and Natural Polymorphisms among HIV-1 Subtype C Infected Patients in Ethiopia.
Arimide DA; Szojka ZI; Zealiyas K; Gebreegziabxier A; Adugna F; Sasinovich S; Björkman P; Medstrand P
Viruses; 2022 Mar; 14(4):. PubMed ID: 35458459
[TBL] [Abstract][Full Text] [Related]
22. Primary resistance to integrase strand transfer inhibitors in Spain using ultrasensitive HIV-1 genotyping.
Casadellà M; Santos JR; Noguera-Julian M; Micán-Rivera R; Domingo P; Antela A; Portilla J; Sanz J; Montero-Alonso M; Navarro J; Masiá M; Valcarce-Pardeiro N; Ocampo A; Pérez-Martínez L; Pasquau J; Vivancos MJ; Imaz A; Carmona-Oyaga P; Muñoz-Medina L; Villar-García J; Barrufet P; Paredes R;
J Antimicrob Chemother; 2020 Dec; 75(12):3517-3524. PubMed ID: 32929472
[TBL] [Abstract][Full Text] [Related]
23. Presence of V72I, G123S and R127K Integrase Inhibitor polymorphisms could reduce ART effectiveness: a retrospective longitudinal study.
Celotti A; Gargiulo F; Quiros-Roldan E; Properzi M; De Francesco MA; Coletto D; Caccuri F; Izzo I; Caruso A; Castelli F; Focà E
HIV Res Clin Pract; 2020 Feb; 21(1):24-33. PubMed ID: 32141388
[No Abstract] [Full Text] [Related]
24. Short Communication: HIV-1 Drug Resistance Mutation Analyses of Cameroon-Derived Integrase Sequences.
Mikasi SG; Isaacs D; Ikomey GM; Shimba H; Cloete R; Jacobs GB
AIDS Res Hum Retroviruses; 2021 Jan; 37(1):54-56. PubMed ID: 32640829
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of Integrase Strand Inhibitor Resistance (INSTI)in New Orleans, Louisiana, 2012-2013.
Jeanfreau K; Sharma S; Frontini M; Khirfan M; Clark RA
J La State Med Soc; 2015; 167(1):19-20. PubMed ID: 25978751
[TBL] [Abstract][Full Text] [Related]
26. Lack of HIV-1 integrase inhibitor resistance among 392 antiretroviral-naïve individuals in a tertiary care hospital in Beijing, China.
Liu L; Dai L; Yao J; Pan P; Li L; Liu Z; An X; Sun L; Wu H; Su B; Zhang T
AIDS; 2019 Oct; 33(12):1945-1947. PubMed ID: 31491787
[TBL] [Abstract][Full Text] [Related]
27. Analysis of HIV-1 integrase genotypes and polymorphisms among integrase inhibitors-based antiretroviral treatment naïve patients in South Sudan.
Giovanetti M; Farcomeni S; Sernicola L; Virtuoso S; Fontanelli Sulekova L; Maggiorella MT; Buttò S; Taliani G; Ciccozzi M; Borsetti A
J Med Virol; 2022 Jul; 94(7):3320-3327. PubMed ID: 35277871
[TBL] [Abstract][Full Text] [Related]
28. Low level of HIV-1C integrase strand transfer inhibitor resistance mutations among recently diagnosed ART-naive Ethiopians.
Kiros M; Tefera DA; Andualem H; Geteneh A; Tesfaye A; Woldemichael TS; Kidane E; Alemayehu DH; Maier M; Mihret A; Abegaz WE; Mulu A
Sci Rep; 2023 Apr; 13(1):6546. PubMed ID: 37085698
[TBL] [Abstract][Full Text] [Related]
29. HIV type 1 integrase polymorphisms in treatment-naive and treatment-experienced HIV type 1-infected patients in Thailand where HIV type 1 subtype A/E predominates.
Phuphuakrat A; Pasomsub E; Kiertiburanakul S; Chantratita W; Sungkanuparph S
AIDS Res Hum Retroviruses; 2012 Aug; 28(8):937-43. PubMed ID: 21970343
[TBL] [Abstract][Full Text] [Related]
30. Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitors.
Ceccherini-Silberstein F; Malet I; Fabeni L; Dimonte S; Svicher V; D'Arrigo R; Artese A; Costa G; Bono S; Alcaro S; Monforte Ad; Katlama C; Calvez V; Antinori A; Marcelin AG; Perno CF
J Antimicrob Chemother; 2010 Nov; 65(11):2305-18. PubMed ID: 20817922
[TBL] [Abstract][Full Text] [Related]
31. HIV-1 Genetic Diversity and Natural Polymorphisms of the Integrase Gene in Integrase Inhibitor-Naive Patients in Harare, Zimbabwe.
Madyadi A; Dhoro M; Shamu T; Washaya T; Kouamou V; Chimukangara B; Katzenstein D; Manasa J
AIDS Res Hum Retroviruses; 2021 Dec; 37(12):954-961. PubMed ID: 34714124
[TBL] [Abstract][Full Text] [Related]
32. HIV-1 Integrase Diversity and Resistance-Associated Mutations and Polymorphisms Among Integrase Strand Transfer Inhibitor-Naive HIV-1 Patients from Cameroon.
Mikasi SG; Gichana JO; Van der Walt C; Brado D; Obasa AE; Njenda D; Messembe M; Lyonga E; Assoumou O; Cloete R; Ikomey GM; Jacobs GB
AIDS Res Hum Retroviruses; 2020 May; 36(5):450-455. PubMed ID: 31830799
[TBL] [Abstract][Full Text] [Related]
33. HIV-1 drug resistance mutations detection and HIV-1 subtype G report by using next-generation sequencing platform.
Gholami M; Rouzbahani N; Samiee S; Tayeri K; Ghorban K; Dehkharghani AD; Gholami AA; Moshiri F; Sattari A; Dadmanesh M; Mohraz M
Microb Pathog; 2020 Sep; 146():104221. PubMed ID: 32360523
[TBL] [Abstract][Full Text] [Related]
34. Circulating HIV-1 Integrase Genotypes in Tanzania: Implication on the Introduction of Integrase Inhibitors-Based Antiretroviral Therapy Regimen.
Masoud S; Kamori D; Barabona G; Mahiti M; Sunguya B; Lyamuya E; Ueno T
AIDS Res Hum Retroviruses; 2020 Jun; 36(6):539-543. PubMed ID: 32126792
[TBL] [Abstract][Full Text] [Related]
35. Molecular evolution of HIV-1 integrase during the 20 years prior to the first approval of integrase inhibitors.
Meixenberger K; Yousef KP; Smith MR; Somogyi S; Fiedler S; Bartmeyer B; Hamouda O; Bannert N; von Kleist M; Kücherer C
Virol J; 2017 Nov; 14(1):223. PubMed ID: 29137637
[TBL] [Abstract][Full Text] [Related]
36. Comparison of an in-house 'home-brew' and commercial ViroSeq integrase genotyping assays on HIV-1 subtype C samples.
Seatla KK; Choga WT; Mogwele M; Diphoko T; Maruapula D; Mupfumi L; Musonda RM; Rowley CF; Avalos A; Kasvosve I; Moyo S; Gaseitsiwe S
PLoS One; 2019; 14(11):e0224292. PubMed ID: 31751353
[TBL] [Abstract][Full Text] [Related]
37. Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings.
Semengue ENJ; Armenia D; Inzaule S; Santoro MM; Dambaya B; Takou D; Teto G; Nka AD; Yagai B; Fabeni L; Chenwi C; Angong Beloumou G; Djupsa Ndjeyep SC; Colizzi V; Perno CF; Ceccherini-Silberstein F; Fokam J
J Antimicrob Chemother; 2021 Apr; 76(5):1277-1285. PubMed ID: 33501504
[TBL] [Abstract][Full Text] [Related]
38. Surveillance of HIV-1 transmitted integrase strand transfer inhibitor resistance in the UK.
Mbisa JL; Ledesma J; Kirwan P; Bibby DF; Manso C; Skingsley A; Murphy G; Brown A; Dunn DT; Delpech V; Geretti AM
J Antimicrob Chemother; 2020 Nov; 75(11):3311-3318. PubMed ID: 32728703
[TBL] [Abstract][Full Text] [Related]
39. Ultradeep sequencing detection of the R263K integrase inhibitor drug resistance mutation.
Jaffré J; Armenia D; Bellocchi MC; Wirden M; Carioti L; Lambert S; Valantin MA; Nguyen T; Simon A; Katlama C; Andreoni M; Perno CF; Calvez V; Ceccherini-Silberstein F; Marcelin AG; Todesco E
J Antimicrob Chemother; 2017 May; 72(5):1537-1539. PubMed ID: 28088769
[No Abstract] [Full Text] [Related]
40. Identification of a new 2-amino acid insertion in the integrase coding region of HIV-1 subtype G isolates.
Pereira-Vaz J; Crespo P; Mocho L; Martinho P; Fidalgo T; Correia L; Rodrigues F; Duque V
J Med Virol; 2021 Nov; 93(11):6388-6392. PubMed ID: 34260070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
